Status:
NOT_YET_RECRUITING
Rapid Diagnosis of Severe Respiratory Tract Infectious Diseases and Screening of Biomarkers for Stratified Diagnosis
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Severe Pneumonia
Biomarkers
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to clarify the biomarkers for rapid diagnosis and stratified diagnosis of severe respiratory tract infectious diseases through clinical experiments.
Detailed Description
Methods: The relationship between relevant biomarkers and stratified diagnosis was analyzed by collecting laboratory and etiological examinations of patients with severe pneumonia.
Eligibility Criteria
Inclusion
- Meets the diagnostic criteria for severe pneumonia；
- Age≥18 years old and \< 80 years old；
- Willing to sign informed consent for the course of the study；
Exclusion
- Patients with intracranial hypertension, acute coronary syndrome, pleural fistula, pneumothorax, or subcutaneous emphysema;
- Pregnant and lactating patients;
- Severely hemodynamically unstable (an increase in vasopressors by more than 30% in the first 6 hours, or norepinephrine \>0.5mg/kg/min);
- Those who do not consent to participate in this study；
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06533514
Start Date
September 1 2024
End Date
December 1 2025
Last Update
August 1 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.